Glykon Scientific Advisors – Harry G. Preuss, MD

Harry G. Preuss, MD, FACN, CNS

Professor of Medicine and Pathology, Georgetown University Medical School.

Three times Past President of the American College of Nutrition.

Profiled in MARQUIS Who’s Who


Glykon Scientific Advisors – Dallas L. Clouatre, Ph.D.

Dallas L. Clouatre, Ph.D., FACN (Glykon Partner)

Dr. Clouatre (A.B., Stanford; Ph.D., UC Berkeley) is widely published on the Metabolic Syndrome (insulin resistance, blood pressure, blood sugar and cardiovascular disease) as well as on nutrition in peer-reviewed medical journals.

In 2004 the World Health Organization (WHO) highlighted his review on Kava-kava toxicity.

Profiled in MARQUIS Who’s Who

Glykon Scientific Advisors – Daniel Clouatre, JD, S.B.

Daniel E. Clouatre, JD, S.B. (Glykon Partner)

Mr. Clouatre is conversant in traditional Chinese Medicine/herbal healing as well as familiar with Indian and Indonesian herbal systems. While in Asia he spent a significant amount of time in the field and production facilities. His near native command of Mandarin Chinese, the lingua franca of East Asia, remains an invaluable asset. Mr. Clouatre earned his S.B. from the Massachusetts Institute of Technology and J.D. from the University of Chicago.

Glykon Scientific Advisors – James M. Dunn, M.D.

JAMES M. DUNN, M.D., FCP, FRSM (Deceased)

1982 International “Men of Achievement” 9th Edition
1982 “Personalities of America” 2nd Edition
1994 Marquis “Who’s Who in Business and Finance” 26th Ed.
1994 Marquis “Who’s Who in the World” 9th Edition
1994 Marquis “Who’s Who in the West 23rd Edition
1995 Marquis “Who’s Who in Science and Engineering” 2nd Ed.
1999 Marquis “Who’s Who in Medicine and Healthcare” 2nd Ed.

Dr. Dunn was the holder of more than one dozen U.S., Canadian, European and South African patents. The major portion of his patent work covers pharmaceutical delivery technologies. He was the author and/or co-author of 44 published scientific papers. For several years, Dr. Dunn was Assistant Professor of Clinical Pharmacology and Medicine at the Louisiana State University School of Medicine.

Co-Inventor of Seven ALS (Glykon) Patents

Glykon Scientific Advisors – Mark Saginor, MD

Mark L. Saginor, M.D., D.H.M., Assistant Clinical Professor (Retired)

“Quite frankly, I had not expected this HCA product to work. You may remember that I have had considerable experience with other commercially available sources of HCA, none of which had any effect, other than that of a placebo, upon appetite and weight. For this reason, I have been quite pleasantly surprised by the very significant appetite reduction induced by Glykon’s HCA. MOREOVER, THIS APPETITE SUPPRESSION APPEARS EVEN IN INDIVIDUALS IN WHOM OTHER APPETITE SUPPRESSANTS HAVE FAILED.”

U.C.L.A. Medical School

Personal physician to Pres. Ronald Reagan